Segment Information (Tables)

9 Months Ended

May 31, 2024

Segment Information

Schedule of profit or loss and total assets for each reportable segment

Nine Months Ended May 31, 2024	IP Licensing			B2B Product			R&D			Corporate			Consolidated Total
Revenue	$	373,990		$	5,388		$	900		$	-		$	380,278
Cost of goods sold		-			(4,822	)		-			-			(4,822	)
Operating expenses		(130	)		(288	)		(1,393,359	)		(2,531,745	)		(3,925,522	)
Other Income(Expense)					-			-			(72,017	)		(72,017	)
Segment Income (Loss)	$	373,860		$	278		$	(1,392,459	)	$	(2,603,762	)	$	(3,622,083	)
Total assets	$	124,968		$	63,573		$	475,194		$	9,354,702		$	10,018,437

Nine Months Ended May 31, 2023	IP Licensing			B2B Product			R&D			Corporate			Consolidated Total
Revenue	$	104,935		$	44,167		$	46,365		$	-		$	195,467
Cost of goods sold		-			(31,500	)		-			-			(31,500	)
Operating expenses		(58,845	)		(235,379	)		(3,166,315	)		(2,123,337	)		(5,583,876	)
Other Income (Expense)					-			-			(43,601	)		(43,601	)
Segment Income (Loss)	$	46,090		$	(222,712	)	$	(3,119,950	)	$	(2,166,938	)	$	(5,463,510	)
Total assets	$	110,997		$	67,705		$	538,571		$	4,522,364		$	5,239,637